Finding the best prices at pharmacies near you...

Prescription & Medication Blog

At RxSpark we believe prescription drugs and medication should be accessible and affordable for all Americans. In addition to the savings, discounts, and convenience that RxSpark provides, the RxSpark Blog is here to bring you information, news, current events, and important upates on topics that affect healthcare and prescription drugs. Be sure to check back frequently for updates, and if you find any information that is particularly helpful please don't hesitate to share!



How to Minimize the Risk of Drug Side Effects

The majority of medication available over-the-counter or with a prescription comes with a risk of side effects, whether minor irritations or more serious health concerns. Each year, emergency rooms across the United States deal with more than 700,000 visits as a result of adverse drug events,...

Read More

FDA Commissioner outlines plans to tackle US opioid epidemic

Scott Gottlieb, MD, US Food and Drug Administration (FDA) Commissioner, has outlined the FDA's plans to tackle the nation's opioid abuse epidemic. Speaking to the House Committee on Energy and Commerce Hearing, he described opioid addiction as the "biggest crisis facing public health...

Read More

Depression 'higher among patients with atopic dermatitis'

Depression and anxiety is more commonly diagnosed in patients suffering atopic dermatitis than among the rest of the US population, a recent survey by the National Eczema Association (NEA) suggests. October is Eczema Awareness Month, during which the NEA is highlighting the impact of eczema on...

Read More

Psoriasis drug Stelara now indicated for adolescent patients

The US Food and Drug Administration (FDA) has approved the indication of Stelara (ustekinumab) for adolescent patients with moderate to severe plaque psoriasis. Janssen Biotech, the manufacturer of the drug, described the approval as a "significant milestone" in the treatment of young people with...

Read More

5 Medical Conditions Where Antibiotics May Be Unnecessary

Antibiotics such as Cipro (ciprofloxacin) and Amoxil (amoxicillin) are prescribed to treat a staggering range of different medical conditions, but their pervasive use could be reducing their efficacy in the long-term. The more these drugs are used, the greater the risk of antibiotic-resistant...

Read More

FDA announces improvements to Adverse Event Reporting System

The US Food and Drug Administration (FDA) has announced improvements to its Adverse Event Reporting System (FAERS). The system is a database of reported medication issues, including product quality complaints leading to adverse events, medication error reports and other adverse event...

Read More

FDA grants for clinical trials 'may lead to lower drug prices'

Over the next four years, more than $22 million in grants have been awarded for clinical trials and research into treatment for patients with rare diseases, the US Food and Drug Administration (FDA) has announced. In a statement released by the regulatory body, FDA Commissioner Scott Gottlieb, MD,...

Read More

FDA approves new pediatric indication for Tracleer

The US Food and Drug Administration has approved a new indication for the Actelion Pharmaceutical's drug Tracleer (bosentan). The medication may now be used to treat pediatric patients aged three and over who suffer from idiopathic or congenital pulmonary arterial hypertension...

Read More